Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study to Evaluate the Efficacy and Safety of Nasal Carbon Dioxide Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2017
Price :
$35
*
At a glance
- Drugs Carbon dioxide (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Capnia
- 03 Feb 2016 New trial record